CAS: 89499-17-2 - (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-({[4-(2-methylpropyl)piperazin-1-yl]amino}methylidene)-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
Formula:C46H64N4O12
InChI:InChI=1/C46H64N4O12/c1-23(2)22-49-16-18-50(19-17-49)47-21-31-36-41(56)34-33(40(31)55)35-43(29(8)39(34)54)62-46(10,44(35)57)60-20-15-32(59-11)26(5)42(61-30(9)51)28(7)38(53)27(6)37(52)24(3)13-12-14-25(4)45(58)48-36/h12-15,20-21,23-24,26-28,32,37-38,42,47,52-54,56H,16-19,22H2,1-11H3,(H,48,58)/b13-12+,20-15+,25-14+,31-21+
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Rifamdin-d4 REF: TR-R507902CAS: 89499-17-2 | - - - | 9.017,00 € | Ven 17 Gen 25 | |
Rifamdin-d9 REF: TR-R507903CAS: 89499-17-2 | - - - | 5.339,00 € | Ven 17 Gen 25 | |
Rifamdin REF: TR-R507900CAS: 89499-17-2 | - - - | 321,00 €~2.043,00 € | Ven 17 Gen 25 | |
Rifamdin REF: 3D-AR27728CAS: 89499-17-2 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 |
Rifamdin-d4
Prodotto ControllatoRef: TR-R507902
50mg | 9.017,00 € |
Rifamdin-d9
Prodotto ControllatoRef: TR-R507903
25mg | 5.339,00 € |
Rifamdin
Prodotto ControllatoRef: TR-R507900
5mg | 321,00 € | ||
50mg | 2.043,00 € |
Rifamdin
Ref: 3D-AR27728
100mg | Prezzo su richiesta |